A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples

Novel technologies are needed to facilitate large-scale detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific antibodies in human blood samples. Such technologies are essential to support seroprevalence studies and vaccine clinical trials, and to monitor quality and dura...

Descripción completa

Detalles Bibliográficos
Autores principales: Swank, Zoe, Michielin, Grégoire, Yip, Hon Ming, Cohen, Patrick, Andrey, Diego O., Vuilleumier, Nicolas, Kaiser, Laurent, Eckerle, Isabella, Meyer, Benjamin, Maerkl, Sebastian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Physical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106336/
https://www.ncbi.nlm.nih.gov/pubmed/33945500
http://dx.doi.org/10.1073/pnas.2025289118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106336/
https://www.ncbi.nlm.nih.gov/pubmed/33945500
http://dx.doi.org/10.1073/pnas.2025289118

Ejemplares similares